Telocyte-derived pentraxin 3 enables vascular pruning as a key driver in infantile hemangioma regression.
Saved in:
| Title: | Telocyte-derived pentraxin 3 enables vascular pruning as a key driver in infantile hemangioma regression. |
|---|---|
| Authors: | Pechtimaldjian L; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France., Jullié ML; Service de Pathologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux F-33000, France., Rousson C; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France., Laanani F; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France., Clachet J; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France., Idrissi Y; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France., Loot M; Service de Chirurgie Pédiatrique, Centre Hospitalier Universitaire de Bordeaux, Bordeaux F-33000, France., Cario-Andre M; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.; Centre de Référence Maladies Rares de la Peau et des Muqueuses d'origine Génétique Sud, Bordeaux F-33000, France.; Aquiderm, Bordeaux F-33000, France., Prey S; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.; Centre de Référence Maladies Rares de la Peau et des Muqueuses d'origine Génétique Sud, Bordeaux F-33000, France.; Service de dermatologie pédiatrique et adulte, Centre Hospitalier Universitaire de Bordeaux, Bordeaux F-33000, France., Taieb A; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France., Leauté-Labrèze C; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.; Centre de Référence Maladies Rares de la Peau et des Muqueuses d'origine Génétique Sud, Bordeaux F-33000, France.; Service de dermatologie pédiatrique et adulte, Centre Hospitalier Universitaire de Bordeaux, Bordeaux F-33000, France., Mathivet T; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France., Moisan F; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France. |
| Source: | Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2026 Jun 16; Vol. 123 (24), pp. e2526271123. Date of Electronic Publication: 2026 Jun 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42268878 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Telocyte-derived pentraxin 3 enables vascular pruning as a key driver in infantile hemangioma regression. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pechtimaldjian+L%22">Pechtimaldjian L</searchLink>; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.<br /><searchLink fieldCode="AU" term="%22Jullié+ML%22">Jullié ML</searchLink>; Service de Pathologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux F-33000, France.<br /><searchLink fieldCode="AU" term="%22Rousson+C%22">Rousson C</searchLink>; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.<br /><searchLink fieldCode="AU" term="%22Laanani+F%22">Laanani F</searchLink>; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.<br /><searchLink fieldCode="AU" term="%22Clachet+J%22">Clachet J</searchLink>; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.<br /><searchLink fieldCode="AU" term="%22Idrissi+Y%22">Idrissi Y</searchLink>; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.<br /><searchLink fieldCode="AU" term="%22Loot+M%22">Loot M</searchLink>; Service de Chirurgie Pédiatrique, Centre Hospitalier Universitaire de Bordeaux, Bordeaux F-33000, France.<br /><searchLink fieldCode="AU" term="%22Cario-Andre+M%22">Cario-Andre M</searchLink>; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.; Centre de Référence Maladies Rares de la Peau et des Muqueuses d'origine Génétique Sud, Bordeaux F-33000, France.; Aquiderm, Bordeaux F-33000, France.<br /><searchLink fieldCode="AU" term="%22Prey+S%22">Prey S</searchLink>; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.; Centre de Référence Maladies Rares de la Peau et des Muqueuses d'origine Génétique Sud, Bordeaux F-33000, France.; Service de dermatologie pédiatrique et adulte, Centre Hospitalier Universitaire de Bordeaux, Bordeaux F-33000, France.<br /><searchLink fieldCode="AU" term="%22Taieb+A%22">Taieb A</searchLink>; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.<br /><searchLink fieldCode="AU" term="%22Leauté-Labrèze+C%22">Leauté-Labrèze C</searchLink>; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.; Centre de Référence Maladies Rares de la Peau et des Muqueuses d'origine Génétique Sud, Bordeaux F-33000, France.; Service de dermatologie pédiatrique et adulte, Centre Hospitalier Universitaire de Bordeaux, Bordeaux F-33000, France.<br /><searchLink fieldCode="AU" term="%22Mathivet+T%22">Mathivet T</searchLink>; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.<br /><searchLink fieldCode="AU" term="%22Moisan+F%22">Moisan F</searchLink>; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227505876%22">Proceedings of the National Academy of Sciences of the United States of America</searchLink> [Proc Natl Acad Sci U S A] 2026 Jun 16; Vol. 123 (24), pp. e2526271123. <i>Date of Electronic Publication: </i>2026 Jun 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22National+Academy+of+Sciences%22">National Academy of Sciences </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7505876 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1091-6490 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200278424%22">00278424 </searchLink><i>NLM ISO Abbreviation: </i>Proc Natl Acad Sci U S A <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42268878 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1073/pnas.2526271123 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e2526271123 Titles: – TitleFull: Telocyte-derived pentraxin 3 enables vascular pruning as a key driver in infantile hemangioma regression. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pechtimaldjian L – PersonEntity: Name: NameFull: Jullié ML – PersonEntity: Name: NameFull: Rousson C – PersonEntity: Name: NameFull: Laanani F – PersonEntity: Name: NameFull: Clachet J – PersonEntity: Name: NameFull: Idrissi Y – PersonEntity: Name: NameFull: Loot M – PersonEntity: Name: NameFull: Cario-Andre M – PersonEntity: Name: NameFull: Prey S – PersonEntity: Name: NameFull: Taieb A – PersonEntity: Name: NameFull: Leauté-Labrèze C – PersonEntity: Name: NameFull: Mathivet T – PersonEntity: Name: NameFull: Moisan F IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 06 Text: 2026 Jun 16 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1091-6490 Numbering: – Type: volume Value: 123 – Type: issue Value: 24 Titles: – TitleFull: Proceedings of the National Academy of Sciences of the United States of America Type: main |
| ResultId | 1 |